BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
FABP1
,
Metabolism of xenobiotics
,
Diabetes mellitus
,
Retina
,
Vitamin E
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
regulation of tau-protein kinase activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Skin
Small intestine
Fallopian tube
Pons
Placenta
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Tinea pedis
Disorder of pregnancy
Infection due to Haemophilus
Hemorrhagic shock
Poisoning by drug AND/OR medicinal substance
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Promegestone
regorafenib
PD 184352
WZ-7043
flavopiridol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
NUP85
MYH7B
CAMK1
EDA
CCDC6
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7.311 cells with CRISPR-induced gene knockouts
L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
L1000 CMAP Lung cancer NCI-H1299 cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for regulation of tau-protein kinase activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Sig…
Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembro…
Nilotinib in Huntington's Disease
Study of ARTS-021 in Patients With Advanced Solid Tumors
Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ